Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Journal of Virology
|
May 20, 2016
Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP
Cecile Rouleau, Arun T Pores Fernando, Justin H Hwang, et al.
Microvascular Research
|
September 2, 2008
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization
Rebecca G Bagley, Nakayuki Honma, William Weber, et al.
International Journal of Oncology
|
April 11, 2009
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs
Rebecca G Bagley, Stephanie Roth, Leslie S Kurtzberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias
Constantine S Mitsiades, Cecile Rouleau, Cinara Echart, et al.
Cancer Chemotherapy and Pharmacology
|
March 12, 2009
Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents
Leslie S Kurtzberg, Stephanie D Roth, Rebecca G Bagley, et al.
Microvascular Research
|
October 1, 2011
Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy
Rebecca G Bagley, Cecile Rouleau, William Weber, et al.
Molecular Cancer Therapeutics
|
July 18, 2015
Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies
Cecile Rouleau, Diego A Gianolio, Robert Smale, et al.
Molecular Cancer Therapeutics
|
August 30, 2008
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248
Rebecca G Bagley, Cecile Rouleau, Thia St Martin, et al.
International Journal of Oncology
|
March 25, 2008
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution
Cecile Rouleau, Krishna Menon, Paula Boutin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2011
Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment
Leslie S Kurtzberg, Stephanie Roth, Roy Krumbholz, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Journal of Virology
|
May 20, 2016
Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP
Cecile Rouleau, Arun T Pores Fernando, Justin H Hwang, et al.
Microvascular Research
|
September 2, 2008
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization
Rebecca G Bagley, Nakayuki Honma, William Weber, et al.
International Journal of Oncology
|
April 11, 2009
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs
Rebecca G Bagley, Stephanie Roth, Leslie S Kurtzberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias
Constantine S Mitsiades, Cecile Rouleau, Cinara Echart, et al.
Cancer Chemotherapy and Pharmacology
|
March 12, 2009
Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents
Leslie S Kurtzberg, Stephanie D Roth, Rebecca G Bagley, et al.
Microvascular Research
|
October 1, 2011
Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy
Rebecca G Bagley, Cecile Rouleau, William Weber, et al.
Molecular Cancer Therapeutics
|
July 18, 2015
Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies
Cecile Rouleau, Diego A Gianolio, Robert Smale, et al.
Molecular Cancer Therapeutics
|
August 30, 2008
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248
Rebecca G Bagley, Cecile Rouleau, Thia St Martin, et al.
International Journal of Oncology
|
March 25, 2008
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution
Cecile Rouleau, Krishna Menon, Paula Boutin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2011
Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment
Leslie S Kurtzberg, Stephanie Roth, Roy Krumbholz, et al.
Page
of 3